Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development
Pascal S Krenger, Magali Roques, Anne-Cathrine S Vogt, Alessandro Pardini, Dominik A Rothen, Ina Balke, Sophie T Schnider, Mona O Mohsen, Volker T Heussler, Andris Zeltins, Martin F Bachmann · 2024
Read Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development by Pascal S Krenger, Magali Roques, Anne-Cathrine S Vogt, Alessandro Pardini, Dominik A Rothen, Ina Balke, Sophie T Schnider, Mona O Mohsen, Volker T Heussler, Andris Zeltins, Martin F Bachmann (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11574195.txt.
Description
Pascal Krenger and co-authors test new vaccine designs against the malaria parasite, in this 2024 paper. The two approved malaria vaccines both target a surface protein of the parasite's infective stage, but neither aims at a junction region that strong human antibodies favor. The team built candidates on a plant virus shell, varying how many repeat units of the protein they show and whether the junction is included.
In mice, more repeat units meant stronger antibody responses and better protection when challenged with a matched parasite. The junction and other extra sites added nothing. The best candidates gave sterile protection even without added boosters, the team reports.
Catalog record
| CREATOR | Pascal S Krenger, Magali Roques, Anne-Cathrine S Vogt, Alessandro Pardini, Dominik A Rothen, Ina Balke, Sophie T Schnider, Mona O Mohsen, Volker T Heussler, Andris Zeltins, Martin F Bachmann |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 79 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |